Plus Therapeutics (PSTV) Short Interest Ratio & Short Volume $0.45 -0.01 (-2.22%) Closing price 04:00 PM EasternExtended Trading$0.46 +0.01 (+2.07%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Plus Therapeutics Short Interest DataPlus Therapeutics (PSTV) has a short interest of 3.12 million shares. This marks a 67.74% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 8.25 million shares to cover all short positions.Current Short Interest3,120,000 sharesPrevious Short Interest1,860,000 sharesChange Vs. Previous Month+67.74%Dollar Volume Sold Short$1.96 millionShort Interest Ratio0.1 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares99,260,000 sharesPercentage of Shares Shorted3.14%Today's Trading Volume4,509,433 sharesAverage Trading Volume8,251,265 sharesToday's Volume Vs. Average55% Short Selling Plus Therapeutics? Sign up to receive the latest short interest report for Plus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPSTV Short Interest Over TimePSTV Days to Cover Over TimePSTV Percentage of Float Shorted Over Time Plus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20253,120,000 shares $1.96 million +67.7%N/A0.1 $0.63 7/31/20251,860,000 shares $898.38 thousand -50.3%3.1%0.1 $0.48 7/15/20253,740,000 shares $1.19 million -34.8%N/A0.1 $0.32 6/30/20255,740,000 shares $2.00 million +390.6%11.7%0.2 $0.35 6/15/20251,170,000 shares $367.38 thousand +128.0%7.2%0.1 $0.31 5/31/2025513,100 shares $145.16 thousand -85.3%9.2%0 $0.28 5/15/20253,490,000 shares $1.77 million +67.8%22.5%0.2 $0.51 4/30/20252,080,000 shares $1.50 million +84.1%12.6%0.1 $0.72 4/15/20251,130,000 shares $735.63 thousand -9.6%6.8%0.1 $0.65 3/31/20251,250,000 shares $1.19 million +34.5%7.5%0.1 $0.95 Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/15/2025929,600 shares $631.01 thousand +562.1%8.1%0.1 $0.68 2/28/2025140,400 shares $101.79 thousand +134.4%2.4%0 $0.73 2/15/202559,900 shares $74.28 thousand -32.2%1.0%1.1 $1.24 1/31/202588,400 shares $108.73 thousand -12.8%1.5%1.2 $1.23 1/15/2025101,400 shares $121.68 thousand -10.6%1.8%1.4 $1.20 12/31/2024113,400 shares $130.41 thousand +20.6%2.0%1.5 $1.15 12/15/202494,000 shares $119.38 thousand -17.5%1.6%1 $1.27 11/30/2024114,000 shares $145.92 thousand +9.6%2.0%1.3 $1.28 11/15/2024104,000 shares $121.68 thousand +98.9%1.8%1.3 $1.17 10/31/202452,300 shares $68.77 thousand -3.2%0.9%0.7 $1.32 10/15/202454,000 shares $76.14 thousand -43.4%0.9%0.9 $1.41 9/30/202495,400 shares $139.28 thousand +81.0%1.7%1.3 $1.46 9/15/202452,700 shares $78.00 thousand +51.0%0.9%1 $1.48 8/31/202434,900 shares $49.91 thousand -58.2%0.6%0.6 $1.43 8/15/202483,500 shares $116.90 thousand -35.3%1.4%1.4 $1.40 7/31/2024129,000 shares $232.20 thousand -39.3%2.3%2.2 $1.80 7/15/2024212,600 shares $389.06 thousand -9.2%3.8%2.4 $1.83 6/30/2024234,100 shares $344.13 thousand +14.0%4.2%3.1 $1.47 6/15/2024205,300 shares $410.60 thousand +19.9%3.7%2.7 $2.00 5/31/2024171,300 shares $378.57 thousand +6.5%3.1%2.4 $2.21 5/15/2024160,800 shares $373.06 thousand +248.8%2.9%2.2 $2.32 4/30/202446,100 shares $80.24 thousand -0.9%1.1%0.7 $1.74 4/15/202446,500 shares $80.91 thousand -0.6%1.1%1.5 $1.74 3/31/202446,800 shares $84.47 thousand +45.3%1.1%1.5 $1.81 3/15/202432,200 shares $55.71 thousand -21.1%0.8%0.9 $1.73 2/29/202440,800 shares $79.15 thousand -12.1%1.0%1.1 $1.94 2/15/202446,400 shares $92.34 thousand +7.2%1.0%1.2 $1.99 1/31/202443,300 shares $87.03 thousand -25.3%1.0%0.6 $2.01 1/15/202458,000 shares $120.06 thousand +21.9%1.3%0.2 $2.07 12/31/202347,600 shares $83.30 thousand -26.3%1.1%0.2 $1.75 12/15/202364,600 shares $123.39 thousand -25.5%1.5%0.2 $1.91 11/30/202386,700 shares $147.39 thousand -59.7%2.0%0.1 $1.70 11/15/2023215,000 shares $406.35 thousand +441.6%4.9%0.3 $1.89 10/31/202339,700 shares $48.43 thousand -43.8%0.9%0.1 $1.22 10/15/202370,600 shares $97.43 thousand -27.6%2.5%0.2 $1.38 9/30/202397,500 shares $130.65 thousand -30.6%3.4%0.2 $1.34 9/15/2023140,500 shares $195.30 thousand +347.5%5.0%0.3 $1.39 8/31/202331,400 shares $87.61 thousand -50.4%1.1%0.1 $2.79 8/15/202363,300 shares $153.82 thousand +76.8%2.2%1.5 $2.43 7/31/202335,800 shares $88.07 thousand +35.6%1.4%1 $2.46 7/15/202326,400 shares $54.65 thousand -13.2%1.1%0.8 $2.07 6/30/202330,400 shares $61.41 thousand -24.6%1.2%1 $2.02 6/15/202340,300 shares $122.51 thousand -3.8%1.6%1.5 $3.04 5/31/202341,900 shares $168.44 thousand -14.3%1.7%1.7 $4.02 5/15/202348,900 shares $213.69 thousand +154.7%2.0%1.9 $4.37 4/30/202319,200 shares $74.82 thousand -66.6%0.8%0.8 $3.90 4/15/202357,500 shares $15.94 thousand -76.7%N/A0.2 $0.28 3/31/2023247,100 shares $71.66 thousand -13.8%N/A0.9 $0.29 3/15/2023286,600 shares $80.39 thousand +4.1%N/A0.9 $0.28 2/28/2023275,400 shares $93.69 thousand -31.4%N/A0.8 $0.34 2/15/2023401,600 shares $156.62 thousand -14.9%N/A1.2 $0.39 1/31/2023472,000 shares $204.52 thousand +17.2%N/A1.4 $0.43 1/15/2023402,600 shares $192.52 thousand +39.7%N/A1.2 $0.48 12/30/2022288,200 shares $91.36 thousand -31.9%N/A0.7 $0.32 12/15/2022423,100 shares $132.01 thousand -5.0%N/A0.6 $0.31 11/30/2022445,200 shares $179.28 thousand -17.8%N/A0.5 $0.40 11/15/2022541,500 shares $234.96 thousand -11.4%N/A0.4 $0.43 10/31/2022610,900 shares $287.12 thousand -50.3%N/A0.1 $0.47 10/15/20221,230,000 shares $642.06 thousand +388.9%N/A0.3 $0.52 9/30/2022251,600 shares $111.96 thousand +74.0%N/A0.1 $0.45 9/15/2022144,600 shares $89.57 thousand -73.5%N/A0 $0.62 8/31/2022545,600 shares $457.98 thousand +865.7%N/A0.1 $0.84 8/15/202256,500 shares $32.04 thousand +289.7%N/A0 $0.57 7/31/202214,500 shares $7.18 thousand -67.5%N/A0.2 $0.49 7/15/202244,600 shares $22.64 thousand +117.6%0.4%0.4 $0.51 6/30/202220,500 shares $11.07 thousand +57.7%0.2%0.1 $0.54 6/15/202213,000 shares $7.28 thousand +106.4%0.1%0.1 $0.56 5/31/20226,300 shares $3.53 thousand -43.2%N/A0 $0.56 5/15/202211,100 shares $5.38 thousand -77.3%N/A0.1 $0.48 4/30/202248,900 shares $32.76 thousand -49.2%N/A0.2 $0.67 4/15/202296,300 shares $87.54 thousand +154.1%N/A0.3 $0.91 3/31/202237,900 shares $37.90 thousand -58.3%N/A0 $1.00 3/15/202290,900 shares $87.26 thousand -69.7%N/A0 $0.96 2/28/2022300,000 shares $312 thousand +11.4%N/A0.1 $1.04 2/15/2022269,400 shares $280.18 thousand -38.3%1.3%0.1 $1.04 1/31/2022436,400 shares $411.96 thousand +70.2%2.9%0.1 $0.94 1/15/2022256,400 shares $264.09 thousand +594.9%1.7%0.1 $1.03 12/31/202136,900 shares $38.75 thousand -0.3%N/A0 $1.05 12/15/202137,000 shares $44.40 thousand -62.7%0.3%0.1 $1.20 11/30/202199,100 shares $148.65 thousand -13.1%0.7%0.3 $1.50 11/15/2021114,000 shares $191.52 thousand +91.6%0.8%0.1 $1.68 10/29/202159,500 shares $113.05 thousand -47.9%0.4%0 $1.90 10/15/2021114,200 shares $199.85 thousand -28.5%0.8%0.1 $1.75 9/30/2021159,600 shares $304.84 thousand -66.0%1.1%0.1 $1.91 9/15/2021469,400 shares $868.39 thousand +121.0%3.1%0.3 $1.85 8/31/2021212,400 shares $414.18 thousand +41.7%1.4%0.2 $1.95 8/13/2021149,900 shares $311.79 thousand -40.8%1.3%0.3 $2.08 7/30/2021253,400 shares $481.46 thousand -14.1%2.1%0.6 $1.90 7/15/2021295,000 shares $660.80 thousand -9.7%2.9%0.3 $2.24 6/30/2021326,700 shares $836.35 thousand -3.9%3.2%0.3 $2.56 6/15/2021340,100 shares $925.07 thousand -65.0%3.7%0.3 $2.72 5/28/2021972,000 shares $2.30 million -28.5%10.7%0.8 $2.37 5/14/20211,360,000 shares $2.77 million +34.7%15.0%1.1 $2.04 4/30/20211,010,000 shares $2.41 million +103.3%11.3%0.6 $2.39 4/15/2021496,700 shares $1.09 million +30.9%5.6%0.5 $2.19 3/31/2021379,600 shares $903.45 thousand +125.3%4.2%0.4 $2.38 3/15/2021168,500 shares $500.45 thousand +12.4%1.9%0.2 $2.97 2/26/2021149,900 shares $449.70 thousand -2.9%1.7%0.2 $3.00 2/12/2021154,300 shares $524.62 thousand +2.7%3.4%0.2 $3.40 1/29/2021150,300 shares $371.24 thousand +440.7%3.3%0.4 $2.47 1/15/202127,800 shares $65.89 thousand -25.1%0.6%0.1 $2.37 12/31/202037,100 shares $77.54 thousand -52.8%0.8%0.1 $2.09 12/15/202078,600 shares $158.77 thousand +104.7%1.8%0.3 $2.02 11/30/202038,400 shares $82.18 thousand -65.5%0.9%0.1 $2.14 11/15/2020111,300 shares $254.88 thousand -29.2%2.5%0.1 $2.29 10/30/2020157,300 shares $353.93 thousand -28.6%3.5%0.2 $2.25 10/15/2020220,400 shares $579.65 thousand -42.1%4.9%0.2 $2.63 9/30/2020380,500 shares $974.08 thousand +29.6%9.1%0.4 $2.56 9/15/2020293,500 shares $889.31 thousand +6.9%7.3%0.3 $3.03 PSTV Short Interest - Frequently Asked Questions What is Plus Therapeutics' current short interest? Short interest is the volume of Plus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 3,120,000 shares of PSTV short. Learn More on Plus Therapeutics' current short interest. Is Plus Therapeutics' short interest increasing or decreasing? Plus Therapeutics saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 3,120,000 shares, an increase of 67.7% from the previous total of 1,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Plus Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Plus Therapeutics: Microbot Medical Inc. (16.99%), Electromed, Inc. (4.54%), LENSAR, Inc. (6.46%), Pro-Dex, Inc. (12.10%), Lakeland Industries, Inc. (14.30%), Profound Medical (2.07%), Avita Medical Inc. (21.94%), Lucid Diagnostics Inc. (13.52%), Jin Medical International Ltd. (0.30%), Inovio Pharmaceuticals, Inc. (10.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Plus Therapeutics stock? Short selling PSTV is an investing strategy that aims to generate trading profit from Plus Therapeutics as its price is falling. PSTV shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Plus Therapeutics? A short squeeze for Plus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PSTV, which in turn drives the price of the stock up even further. How often is Plus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PSTV, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies Microbot Medical Short Squeeze Electromed Short Squeeze LENSAR Short Squeeze Pro-Dex Short Squeeze Lakeland Industries Short Squeeze Profound Medical Short Squeeze Avita Medical Short Squeeze Lucid Diagnostics Short Squeeze Jin Medical International Short Squeeze Inovio Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PSTV) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is hereWashington just added $1 trillion to the national debt in less than two months — an astonishing pace of spendi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
